N-Nitroso Tofacitinib
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

N-Nitroso Tofacitinib

● Failure Report (NAP Test) Available

카탈로그 번호:VE009521
CAS 번호:N/A
분자식:C16H19N7O2
분자량:341.4 g//mol

에 대한 추가 정보 N-Nitroso Tofacitinib

모약물

Tofacitinib

IUPAC명

3-((3R, 4R)-4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

약전 동의어

Tofacitinib Nitroso Impurity 1

Other Synonyms

N/A

SMILES

N#CCC(N1C[C@H](N(C)C2=C3C(N(N=O)C=C3)=NC=N2)[C@H](C)CC1)=O

InChI

InChI=1S/C16H19N7O2/c1-11-4-7-22(14(24)3-6-17)9-13(11)21(2)15-12-5-8-23(20-25)16(12)19-10-18-15/h5,8,10-11,13H,3-4,7,9H2,1-2H3/t11-,13+/m1/s1

설명

N-Nitroso Tofacitinib is an N-nitroso derivative of the secondary amine present in Tofacitinib which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds including those set by USP, EMA, JP, and BP. This nitroso standard is essential for a variety of applications such as analytical method development method validation (AMV) and Quality Control (QC) particularly in the context of Tofacitinib production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits quantify impurity levels and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

N-Nitroso Tofacitinib: Synthesis Attempts and Failure Report (NAP Test)

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url